AGP Executive Report
Last update: 9 hours agoWorkplace Safety: Massachusetts reports a relentless assault rate—every 36 minutes a hospital worker faces verbal threats, physical assault, or abuse—fueling calls for urgent legislative protections. Behavioral Health: North Dakota opened registration for its Sept. 14-17 Behavioral Health & Children and Family Services Conference, spotlighting suicide prevention, youth development, and evidence-based care. Diabetes Access: Australia’s PBS will list Tresiba Penfill (insulin degludec) from July 1, expanding affordable basal insulin options for people with type 1 diabetes. Allergy Emergency Care: CSL Seqirus says neffy® adrenaline nasal spray is now PBS-listed from July 1 for eligible Australians at risk of anaphylaxis. Cancer Pipeline: Actinium-225 rosopatamab tetraxetan showed encouraging activity in a phase 2 trial for metastatic castration-resistant prostate cancer after Lu-177-PSMA therapy, with a manageable safety profile. Digital Health Policy: Malaysia’s Basic MHIT plan pilot is set to begin by end of July, using selected insurers and private hospitals to refine rollout. Market & Innovation: Alebund Pharmaceuticals (kidney-focused) listed on HKEx Main Board, while researchers report Arc may help explain how Alzheimer’s tau spreads between neurons.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
